Microarray profile of the humoral immune response to influenza vaccination in breast cancer patients treated with chemotherapy

ML Wumkes; AMT van der Velden; Erwin de Bruin; A Meerveld-Eggink; Marion Koopmans; Guus Rimmelzwaan; GT Rijkers; DH Biesma

doi:10.1016/j.vaccine.2017.01.039

Microarray profile of the humoral immune response to influenza vaccination in breast cancer patients treated with chemotherapy

ML Wumkes, AMT van der Velden, Erwin de Bruin, A Meerveld-Eggink, Marion Koopmans, Guus Rimmelzwaan, GT Rijkers, DH Biesma

Virology

Research output: Contribution to journal › Article › Academic › peer-review

7 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1299-1305
Number of pages	7
Journal	Vaccine
Volume	35
Issue number	9
DOIs	https://doi.org/10.1016/j.vaccine.2017.01.039
Publication status	Published - 2017

Research programs

EMC OR-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.vaccine.2017.01.039

http://hdl.handle.net/1765/95803

Cite this

@article{0a4c4946f2f04de58c2b15df448a2109,

title = "Microarray profile of the humoral immune response to influenza vaccination in breast cancer patients treated with chemotherapy",

author = "ML Wumkes and {van der Velden}, AMT and {de Bruin}, Erwin and A Meerveld-Eggink and Marion Koopmans and Guus Rimmelzwaan and GT Rijkers and DH Biesma",

year = "2017",

doi = "10.1016/j.vaccine.2017.01.039",

language = "Undefined/Unknown",

volume = "35",

pages = "1299--1305",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier",

number = "9",

}

TY - JOUR

T1 - Microarray profile of the humoral immune response to influenza vaccination in breast cancer patients treated with chemotherapy

AU - Wumkes, ML

AU - van der Velden, AMT

AU - de Bruin, Erwin

AU - Meerveld-Eggink, A

AU - Koopmans, Marion

AU - Rimmelzwaan, Guus

AU - Rijkers, GT

AU - Biesma, DH

PY - 2017

Y1 - 2017

U2 - 10.1016/j.vaccine.2017.01.039

DO - 10.1016/j.vaccine.2017.01.039

M3 - Article

C2 - 28169075

SN - 0264-410X

VL - 35

SP - 1299

EP - 1305

JO - Vaccine

JF - Vaccine

IS - 9

ER -